Wedbush Maintains Outperform on Zura Bio, Lowers Price Target to $10
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice Target
Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $22 to $10.
Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $22 to $10.